Skip to search formSkip to main contentSkip to account menu

MI 1544

Known as: D-Alaninamide, N-acetyl-D-tryptophyl-4-chloro-D-phenylalanyl-D-tryptophyl-L-seryl-L-tyrosyl-D-lysyl-L-leucyl-L-arginyl-L-prolyl-, (6R-(6alpha,7beta(Z)))-, MI-1544 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Gonadorelin
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
Influence on antiproliferative activity of structural modification and conjugation of gonadotropin‐releasing hormone (GnRH) analogues
The effect of various GnRH analogues, and their conjugates on proliferation, clonogenicity and cell cycle phase distribution of… 
1998
1998
Electrochemical Stimulation of the Median Eminence Evokes FSH but not LH Release After LHRH Antagonist Treatment
Experimental data suggest that a follicle stimulating hormone‐releasing factor (FSH‐RF) distinct from luteinizing hormone… 
1996
1996
Synthesis, conformation, biodistribution, and hormone-related in vitro antitumor activity of a gonadotropin-releasing hormone antagonist-branched polypeptide conjugate.
Since permanently high levels of GnRH analogues are necessary to exert direct and/or indirect antitumor effect on mammary tumors… 
1996
1996
Effect of gonadotropin-releasing hormone analogs and their conjugates on gonadotropin-releasing hormone receptor--positive human cancer cell lines.
The purpose of the present investigation was to develop new gonadotropin-releasing hormone (GnRH) antagonists and to increase… 
1996
1996
In vivo studies of the new gonadotropin-releasing hormone antagonist--copolymer conjugates having antitumor activity.
The aim of the study was to test in vivo the gonadotropin-releasing hormone (GnRH) antagonists and their conjugates showing… 
1994
1994
Antitumour effect of a gonadotropin-releasing-hormone antagonist (MI-1544) and its conjugate on human breast cancer cells and their xenografts
Our gonadotropin-releasing hormone (GnRH) antagonist analogue MI-1544 ([Ac-d-Trp1,3,d-Cpa2,d-Lys6,d-Ala10]GnRH) was developed as… 
1993
1993
Antiovulatory Doses of Antagonists of LH‐RH Inhibit LH and Progesterone but not FSH and Estradiol Release
The differential regulation of immunoactive FSH and LH secretion by endogenous LH‐RH was studied using LH‐RH antagonists (Ac‐D… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)